Sharekhan   

@Sharekhan

#SharekhanFNA #SharekhanResearch #Q2FY21 expected to be healthy qtr for pharma cos; Exports to largely drive the performance; sales to grow 7.6% yoy while PAT to grow 14.5% Prefer#Aurobindo#Cipla#DivisLab#LaurusLab#Granules#SanofiIndi#AbbottIndia#StridesPharma#ShilpaMedicare

09/10/2020 09:11:30 AM     Share:    

---

  ETHealthWorld   

@ETHealthWorld

ETHealthworld | Abbott Launches Duphalac Bears in India #Constipation #DigestiveSystem #AbbottIndia #DuphalactmBears #DigestiveHealth #Lactulose

08/10/2020 10:30:22 PM     Share:    

---

  Markets Today   

@marketst0day

Today's #Infographic: The Fat Dividend Paying Pharma Companies by @DhanValue Includes: 1. Pfizer 2. Sanofi 3. Abbott India 4. Torrent Pharma 5. Alembic Pharma 6. Piramal Enterprises

06/10/2020 08:19:56 AM     Share:    

---

  ETMarkets   

@ETMarkets

Buy Abbott India, target price Rs 19,314: ICICI Securities #ETMarkets #DailyRecos #StockPicks #DailyPicks

15/09/2020 12:42:22 PM     Share:    

---

  GEPL Capital   

@GEPLCapital

Trading Tweaks 💫AGM Date: Abbott India, Aditya Birla Fashion Retail, Indiabulls Housing Finance, NACL (cont) https://t.co/9RogPXyxpf

07/09/2020 09:30:47 AM     Share:    

---

  ETMarkets   

@ETMarkets

Buy Abbott India, target price Rs 19,200: Centrum Broking #ETMarkets #DailyRecos #StockPicks #DailyPicks

04/09/2020 12:42:11 PM     Share:    

---

  GEPL Capital   

@GEPLCapital

Trading Tweaks 🔆AGM Date: Ashok Leyland, Ramco Industries, Ramco Systems, Abbott India, Fermenta Biotech. (cont) https://t.co/dz4UiN4mwZ

28/08/2020 09:17:41 AM     Share:    

---

  Nickey   

@OnlyNickey

ABBOTT INDIA In Focus Can be Negative for Thyrocare, Dr lal

27/08/2020 09:00:04 AM     Share:    

---

  Business Standard   

@bsindia

According to analysts at ICICI Securities, growth was supported by the anti-diabetes portfolio of Novo Nordisk as the core portfolio of Abbott India is largely in acute therapy.

20/08/2020 09:55:00 AM     Share:    

---

  Safir   

@safiranand

Reading Icici sec sees margins improving by 470 bp for Abbott india over next 2 years driven by branded business, focus on digital mktg, operating leverage in core portfolio. Coupled with healthy earning growth, free cash flows of 1800 cr could flow over this period.

20/08/2020 09:12:26 AM     Share:    

---

  Sharekhan   

@Sharekhan

#SharekhanFNA #SharekhanResearch retains Neutral view on #Pharmaceutical sector Q1FY21 was strong quarter for Pharma cos; though valuations seem reasonable for most cos US bizz likely to be under stress; preferred picks #Divislabs#LaurusLabs #Granules #SanofiIndia #Abbott India

20/08/2020 09:00:54 AM     Share:    

---

  Equityboxx Research   

@Equityboxx

CLSA On Abbott India Buy rating maintained Price target of Rs 20,000 For daily Buy/Sell calls, Subscribe here:

19/08/2020 11:42:06 AM     Share:    

---

  CNBC-TV18   

@CNBCTV18News

Morgan Stanley and Macquarie are bullish on Zee despite its weak June-quarter numbers while CLSA has a 'buy' call on Abbott India. Here are the top brokerage calls for today:

19/08/2020 09:24:52 AM     Share:    

---

  ET NOW   

@ETNOWlive

#BrokerageRadar: CLSA on Abbott India

19/08/2020 08:01:28 AM     Share:    

---

  CNBC-TV18   

@CNBCTV18Live

#CNBCTV18Market | CLSA reiterates BUY call on Abbott India, sets target at Rs 20,000/sh

19/08/2020 06:57:31 AM     Share:    

---

  ETMarkets   

@ETMarkets

Buy Abbott India, target price Rs 18,500: Axis Securities #ETMarkets #DailyRecos #StockPicks #DailyPicks

18/08/2020 12:42:07 PM     Share:    

---

  EquityBulls.com   

@equitybulls

Abbott India - Strong performance despite challenges - ICICI Securities #AbbottIndia @ICICI_Direct #ICICISecurities

12/08/2020 01:20:52 PM     Share:    

---

  Dalal Street Journal   

@DSIJ

Q1FY21 results: Abbott India profit jumps by 54.22 per cent YoY to Rs 180.35 crore

10/08/2020 10:01:12 AM     Share:    

---

  Sharekhan   

@Sharekhan

#SharekhanFNA #SharekhanResearch retains Positive view on #AbbottIndia (upside 18-20%); strong results for Q1FY21; power brands have leadership position in their respective segment & growth traction to sustain; better earning visibility strong balance sheet & cashflow augur well

10/08/2020 09:11:43 AM     Share:    

---

  Markets Today   

@marketst0day

#Abbott India: The company reported a 54.22% rise in its net profit to ₹180.35 crore for the quarter to June 2020. Abbott India had posted a net profit of ₹116.94 crore for the corresponding period of the previous fiscal.

10/08/2020 08:27:45 AM     Share:    

---